American Journal of Ophthalmology Case Reports (Dec 2023)

Scleral ectasia stabilization following intra-arterial chemotherapy in an eye with recurrent retinoblastoma

  • Warren Pan,
  • Neeraj Chaudhary,
  • Laura Sedig,
  • Amy Edmonds,
  • Raymond Hutchinson,
  • Hakan Demirci

Journal volume & issue
Vol. 32
p. 101941

Abstract

Read online

Purpose: To report a case of recurrent retinoblastoma following transpupillary thermotherapy (TTT) with development of scleral ectasia, as well as their successful treatment with intra-arterial chemotherapy. Observations: A 15-month-old girl with bilateral retinoblastoma presented with recurrent retinoblastoma and associated scleral ectasia with concern for extraocular extension after receiving multiple round of systemic chemotherapy and TTT. Given her negative systemic evaluation, decision was made to pursue intra-arterial chemotherapy. After completion of six rounds of 3-agent intra-arterial chemotherapy, the recurrent retinoblastoma had completely regressed and the scleral ectasia had improved and fibrosed. Conclusions and importance: The sclera is classically viewed as hyperthermy-resistant to TTT. Here, we describe scleral ectasia due to aggressive TTT with recurrence of the retinoblastoma. Our treatment with intra-arterial chemotherapy not only caused complete regression of the recurrent retinoblastoma, but it also contributed to the stabilization and improvement of the weakened scleral.

Keywords